Investigators identified optimal combinations of human leukocyte antigen/KIR donor-patient pairing, conditioning, and immunosuppressive regimens in pediatric patients with acute lymphoblastic or acute myeloblastic leukemia undergoing umbilical cord blood transplantation.
[Transplantation and Cellular Therapy]